Dear Editor, Detection of mRNA in blood samples is emerging as a potential biomarker of diagnosis or prognosis of disease [1, 2] . However, pre-analytical variations in mRNA expression can occur because of a delay in blood processing [3, 4] . In microarray-based transcriptome analysis, gene expression in blood cells was significantly altered by delayed blood sample processing (room temperature ≥ 2 hours) [3, 4] . There are no published studies of the effects of delayed blood sample processing on next generation sequencing for transcriptome analysis. This study was designed to address this.. Briefly, double-stranded cDNA was synthesized using the cDNA Synthesis System (Roche Diagnostics, Mannheim, Germany), was fractionated into 600-900 bp fragments via nebulization by compressed nitrogen gas, and then cDNA fragments were ligated to 2 adaptors for 3' and 5' ends.
Following purification and quantitation, DNA libraries were used for emulsion PCR (emPCR) and bead enrichment.
Sequencing was carried out using the GS Junior Titanium Sequencing Kit (Roche Diagnostics). Contig assembly was performed using CLC Genomic Workbench 6 (CLC bio, Aarhus, Denmark).
To evaluate the effects of delayed blood processing on RNAseq analysis, concentrations of RNA, RIN, and the number of contigs were assessed from the same volume of blood prepared directly following collection, or after cold storage (4°C) for either 24 hours or 48 hours ( Table 1 ).
The concentration of RNA was much lower in blood sample (13 ng/µL) that was stored at 4°C for 48 hours compared to the blood sample (34 ng/µL) that was prepared immediately. sample prepared immediately after blood collection. These genes are putative mRNA biomarkers in peripheral blood for progression or severity of hepatocellular carcinoma [5] and coronary artery disease [6] , respectively.
These findings indicate that the processing condition of blood samples may affect the diagnosis of disease using mRNA biomarkers. Contrary to this result, CCR2 expression in microarray data has been shown to decrease with delayed processing. The difference between studies supports findings that pre-analytical variations can depend on the assay method [7] .
In conclusion, the impact of delayed blood processing on next generation sequencing data for transcriptome analysis has been identified. This study has found that the quantity and quality of RNA in a blood sample was sensitive to time from collection to processing. The number of detectable transcripts decreased and expression patterns of transcripts including putative mRNA biomarkers, altered according delayed processing. Our study suggests that a blood sample with a longtime-delay from blood collection to processing, should not 
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